Gene · 4920
Papers2,066
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,066
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Uric acid-based ratios for predicting renal failure in Chinese IgA nephropathy patients. | Int J Med Sci | 2023 | 37859692 | PubTator, text mining | PubMed |
| Pan-cancer analysis identifies RNF43 as a prognostic, therapeutic and immunological biomarker. | Eur J Med Res | 2023 | 37848933 | PubTator, text mining | PubMed |
| Rho-Kinase Inhibitors as Emerging Targets for Glaucoma Therapy. | Ophthalmol Ther | 2023 | 37837578 | PubTator, text mining | PubMed |
| ROR2 homodimerization is sufficient to activate a neuronal Wnt/calcium signaling pathway. | J Biol Chem | 2023 | 37832874 | PubTator, text mining | PubMed |
| Targeting endoplasmic reticulum stress signaling in ovarian cancer therapy. | Cancer Biol Med | 2023 | 37817482 | PubTator, text mining | PubMed |
| Altered binding affinity of SIX1-Q177R correlates with enhanced WNT5A and WNT pathway effector expression in Wilms tumor. | Dis Model Mech | 2023 | 37815464 | PubTator, text mining | PubMed |
| Lymph Node Dissection in Upper Tract Urothelial Carcinoma: Current Status and Future Perspectives. | Curr Oncol Rep | 2023 | 37801187 | PubTator, text mining | PubMed |
| Integrated bioinformatics analysis for the identification of idiopathic pulmonary fibrosis-related genes and potential therapeutic drugs. | BMC Pulm Med | 2023 | 37794454 | PubTator, text mining | PubMed |
| Editorial: Chondrogenic potentials, protocols and mechanisms of mesenchymal progenitor cells. | Front Cell Dev Biol | 2023 | 37786809 | PubTator, text mining | PubMed |
| Detection of receptor tyrosine kinase-orphan receptor-2 using an electrochemical immunosensor modified with electrospun nanofibers comprising polyvinylpyrrolidone, soy, and gold nanoparticles. | Mikrochim Acta | 2023 | 37770707 | PubTator, text mining | PubMed |
| Endothelial Dysfunction in Cardiorenal Conditions: Implications of Endothelial Glucocorticoid Receptor-Wnt Signaling. | Int J Mol Sci | 2023 | 37762564 | PubTator, text mining | PubMed |
| Anti-Inflammatory Effects of Peripheral Dopamine. | Int J Mol Sci | 2023 | 37762126 | PubTator, text mining | PubMed |
| Conditionally Active, pH-Sensitive Immunoregulatory Antibodies Targeting VISTA and CTLA-4 Lead an Emerging Class of Cancer Therapeutics. | Antibodies (Basel) | 2023 | 37753969 | PubTator, text mining | PubMed |
| Plasma cells in human pancreatic ductal adenocarcinoma secrete antibodies against self-antigens. | JCI Insight | 2023 | 37751306 | PubTator, text mining | PubMed |
| ROR2 deficit may induce the tetralogy of Fallot via down-regulating of β-catenin/SOX3/HSPA6 in vitro and in vivo. | J Cell Mol Med | 2023 | 37749917 | PubTator, text mining | PubMed |
| Uncovering therapeutic opportunities in the clinical development of antibody-drug conjugates. | Clin Transl Med | 2023 | 37740463 | PubTator, text mining | PubMed |
| Hyperglycemia increases SCO-spondin and Wnt5a secretion into the cerebrospinal fluid to regulate ependymal cell beating and glucose sensing. | PLoS Biol | 2023 | 37733692 | PubTator, text mining | PubMed |
| Emerging proteins involved in castration‑resistant prostate cancer via the AR‑dependent and AR‑independent pathways (Review). | Int J Oncol | 2023 | 37732538 | PubTator, text mining | PubMed |
| Cancer-associated fibroblasts influence Wnt/PCP signaling in gastric cancer cells by cytoneme-based dissemination of ROR2. | Proc Natl Acad Sci U S A | 2023 | 37722040 | PubTator, text mining | PubMed |
Belgian Endothelial Surgical Transplant of the Cornea (BEST cornea) protocol: clinical and patient-reported outcomes of Ultra-Thin Descemet Stripping Automated Endothelial Keratoplasty (UT-DSAEK) versus Descemet Membrane Endothelial Keratoplasty (DMEK) - a multicentric, randomised, parallel group pragmatic trial in corneal endothelial decompensation. | BMJ Open | 2023 | 37714670 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4920/papers?page=8